Context:

Our friends at Upstream and Imperial College London are pleased to extend an invitation to OneNucleus members to their event on clinical trials. Jawdrop Fireside: Unleashing the Power of Clinical Trials will take place on 31 October at the Molecular Sciences Research Hub (MSRH), on Imperial College London's White City campus.  The event will convene industry, the NHS & academia to explore how the use of clinical trials can drive UK Life Science innovation & patient outcomes. 

Jawdrop Fireside Life Sciences brings together industry leaders, NHS representatives, and academic experts to explore how the use of clinical trials can drive innovation and improve patient outcomes. In an increasingly competitive global environment, the number of industry clinical trials initiated in the UK per year fell by 41% between 2017 and 2021. This challenge is clearly recognised by Government, regulatory and professional bodies; the panel will debate the Government’s proposals on clinical trials, the importance of fostering collaboration between industry, the NHS, and academia as well as the ethical and regulatory considerations.

Keynotes:

Opening: Dr June Raine DBE, CEO, Medicines and Healthcare products Regulatory Agency (MHRA)

Closing: Dr Suki Balendra, Imperial College Healthcare NHS Trust, Director of Strategic Partnerships at Paddington Life Sciences & Life sciences Lead for the NIHR CRN North West London

Panel - more speakers to be confirmed

• Prof. Graham Cooke, Imperial College London, Vice Dean (Research) for the Faculty of Medicine (Chair)
• Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare NHS Trust
• Rob Hastings, Medical Affairs Director - Novartis UK
• Angela McFarlane, Vice President, Strategic Planning, Northern Europe, IQVIA
• Nahuel Villegas, CSO - Vivan Therapeutics

 
Tickets are free and include a networking reception.  

For more info and to register, click here.